Followers | 436 |
Posts | 31258 |
Boards Moderated | 1 |
Alias Born | 11/28/2006 |
Tuesday, August 27, 2019 11:42:54 AM
good questions/comments/concerns! THANK YOU, I got all 4 of them ...i just finished my lecture LOL i added all that to the end of the call like a conference call basically..which damn thats another good question! soo many but ill leave that one out because what Im sharing is this (inferred, implied)... (IGNORE TYPOS, i just was scribbling on the virtual post it note) i think together we just about covered everything lol....i gotta rest up for this call LOL. I really hope their is going to be director on the line because i originally asked for my message to be fwd to the company to a director, thats when things got serious so fingers crossed
heres what i have so far, im open to constructive criticism:
can we get on a recorded line?
Do you trade or invest in any companies other than DSS? I imagine your shares were employee compensation because if it was your hard earned money I dont know how you could watch it just bleed from 28 bucks to .40 cents,..but anyway...
my concern is very simple, if you look at most companies that are public, they OFTEN press release or are emntioned in articles , or subjects etc, more popular ones even have multiple actions and activity on same day! even the occasional "fluffer" news would be welcomed in our situation which is not a good look...but news is news and getting the companies message and deciphering their moves for the public hasnt hahd much affect on stock price, every time a rally gets started theres a feeling of "dumping" immediately because people im sure know its gonna get dragged down again
ive h ad this conversation before with other companies and I often get the "shorts" excuse....well if one wants to battle and win against short sellers which can easilyt dominate a low volume average stock like this is like shooting fish in a barrel...
By now, ive estimated the offering shares have already been commited to sells or holds , i mean the shares were purchased at .50 cents and its been quite a while and volume plus exchange activity ( through level 2 + 3, and it cant teven hold .50!
so its one of twocauses likely in my opinion
a. bigger investors that dont fall in top 10% are shorting or selling at loss still (or the offering buyers are selling at loss
b. which i THINK is the problem, just like in other stocks with low volume their is no fear to cover immediately and not short because they are aware of the stocks history of "blandness"...... a company (even those with no profit in sight for 10 years like uber) are constantly saying THINGS, anything, but this quitness for 6 months Is NOT working, im shocked its stuck like glue in this range and as trader I will tell you this long of a period at a level will usually breakdown supports. and encourage more shhort selling..
in a scenario where the company under promises and over delivers, you willl see much less "bullying" ill say....
either way, there is nothing reported yet as sells from insiders so whats going on? if anything there should be prs galore with the new "subsidiary" that has FOUR elemnts and avenues
...so what is the company doijng to address this because looking at a full 33 years whuich is not th e max but the max the schart will sh ow me through the platofrm.....obviously their seems to be a snag somewhere cuz this is very unacceptable.....
please commicate this call with them by all means
NOW I HAVE SOME OTHER QUESTIONS/CONCERNS FROM INVESTORS IF YOU COULD ANSWER THEM
Thanks.
1) are we in communication with any pharmecital companies , to use authentiguard?
2) what was the reason to start the other subsidies. when we cant even get our flagship product rolled out even minimally. Medical products cost millions of dollars and nothing is assured to be successfull.
3) why where these new directors given free shares of stock?? Shouldnt they bring something onboard before the rewards are issued??
4) 4) it won't be long before we are sent a notice to be delisted. What are the concerns of the company on this. 5) does the company need to. Install new printers/ labeler. For our authentiguard to be used.or can dss. Equipment already installed. If a company want to use our product..
Recent DSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:15:31 PM
- Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." • GlobeNewswire Inc. • 01/30/2024 01:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:54:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:40 PM
- DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market • GlobeNewswire Inc. • 01/04/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:10:36 PM
- DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan • GlobeNewswire Inc. • 12/22/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:30:23 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/13/2023 09:15:25 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/01/2023 09:15:06 PM
- Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years • GlobeNewswire Inc. • 11/28/2023 01:10:00 PM
- DSS Inc. Wins Patent Dispute with Nichia Corporation • GlobeNewswire Inc. • 11/14/2023 01:00:00 PM
- DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock • GlobeNewswire Inc. • 11/08/2023 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 09:25:10 PM
- DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule • GlobeNewswire Inc. • 10/26/2023 09:25:00 PM
- DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical • GlobeNewswire Inc. • 10/23/2023 12:25:00 PM
- DSS Inc. Issues Letter to Shareholders • GlobeNewswire Inc. • 10/12/2023 12:25:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:31:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:30:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/12/2023 08:30:20 PM
- DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary • GlobeNewswire Inc. • 09/06/2023 12:40:00 PM
- DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. • GlobeNewswire Inc. • 07/31/2023 12:15:00 PM
- DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc. • GlobeNewswire Inc. • 07/05/2023 12:15:00 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM